ImmunoBrain immunotherapy shows success in Alzheimer's treatment
ImmunoBrain presented early-stage data on a novel approach targeting the peripheral immune system to break the cycle between neuroinflammation and immune decline, showing efficacy beyond amyloid and tau targets.
- Field
- medicine and diagnostics
- What they did
- ImmunoBrain has generated early clinical data showing success for an immunotherapy approach that treats Alzheimer's by restoring the body's peripheral immune system, rather than just targeting amyloid plaques and tau tangles.
- Why it matters
- This could benefit patients with Alzheimer's and other neurodegenerative diseases by breaking the vicious cycle between brain inflammation and declining peripheral immune function.
#alzheimer's#immunotherapy#neuroinflammation#clinical trial


